First Eagle Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-6,667
| Closed | -$91K | – | 161 |
|
2018
Q4 | $91K | Hold |
6,667
| – | – | ﹤0.01% | 159 |
|
2018
Q3 | $143K | Sell |
6,667
-77,694
| -92% | -$1.67M | ﹤0.01% | 160 |
|
2018
Q2 | $3.61M | Sell |
84,361
-176,339
| -68% | -$7.55M | 0.01% | 142 |
|
2018
Q1 | $17M | Sell |
260,700
-33,156
| -11% | -$2.16M | 0.04% | 118 |
|
2017
Q4 | $21.4M | Buy |
293,856
+16,723
| +6% | +$1.22M | 0.05% | 125 |
|
2017
Q3 | $25.4M | Buy |
277,133
+5,555
| +2% | +$509K | 0.06% | 135 |
|
2017
Q2 | $18M | Buy |
271,578
+16,111
| +6% | +$1.07M | 0.04% | 141 |
|
2017
Q1 | $55.4M | Buy |
255,467
+18,889
| +8% | +$4.1M | 0.14% | 98 |
|
2016
Q4 | $21.9M | Sell |
236,578
-6,389
| -3% | -$591K | 0.06% | 140 |
|
2016
Q3 | $32.8M | Hold |
242,967
| – | – | 0.08% | 133 |
|
2016
Q2 | $24.6M | Buy |
242,967
+48,000
| +25% | +$4.86M | 0.06% | 150 |
|
2016
Q1 | $31.9M | Sell |
194,967
-4,277
| -2% | -$701K | 0.08% | 136 |
|
2015
Q4 | $65.3M | Sell |
199,244
-9,267
| -4% | -$3.04M | 0.16% | 115 |
|
2015
Q3 | $67.3M | Buy |
208,511
+17,444
| +9% | +$5.63M | 0.17% | 113 |
|
2015
Q2 | $76.1M | Buy |
191,067
+32,100
| +20% | +$12.8M | 0.18% | 106 |
|
2015
Q1 | $78.3M | Buy |
158,967
+2,702
| +2% | +$1.33M | 0.19% | 103 |
|
2014
Q4 | $55.9M | Buy |
156,265
+16,530
| +12% | +$5.91M | 0.14% | 117 |
|
2014
Q3 | $26.9M | Sell |
139,735
-5,484
| -4% | -$1.06M | 0.07% | 149 |
|
2014
Q2 | $34.7M | Buy |
145,219
+16,130
| +12% | +$3.85M | 0.08% | 139 |
|
2014
Q1 | $33M | Buy |
129,089
+28,516
| +28% | +$7.29M | 0.09% | 118 |
|
2013
Q4 | $19.9M | Buy |
100,573
+14,089
| +16% | +$2.79M | 0.05% | 131 |
|
2013
Q3 | $14.6M | Buy |
86,484
+15,200
| +21% | +$2.57M | 0.04% | 147 |
|
2013
Q2 | $12.7M | Buy |
+71,284
| New | +$12.7M | 0.04% | 164 |
|